EUVIMEDEUVIMED entdecken
Crossref

Osteoblast‐derived exosomal miR ‐140‐3p targets ACER2 and increases the progression of prostate cancer via the AKT/mTOR pathway‐mediated inhibition of autophagy

Ying Liu iD, Shisheng Chen iD, Kuo Guo iD, Siyuan Ma iD, Xi Wang iD, Qianping Liu iD, Rongxin Yan iD, Yuerong Huang iD, Tian Li iD, Shuhua He iD, Jialiang Hui iD

The FASEB Journal · 15.12.2024 · 38 (23)

DOI: 10.1096/fj.202401480r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 03.12.2024. Verfasst von Ying Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Huadu Hospital, Southern Medical University (People's Hospital of Huadu District), Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: MicroRNAs, Prostatic Neoplasms, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Science and Technology Projects in Guangzhou, Science and Technology Planning Project of Huadu District, Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced prostate cancer (aPCa) often results in bone metastases (BM). However, the mechanism underlying its progression and metastasis to bones remains unclear. Therefore, we examined whether exosomal miR‐140‐3p affects prostate cancer (PCa) progression. We obtained from cell lines, clinical data analyses, and animal models consistently provide important evidence. Patients with PCa having BM had higher miR‐140‐3p expression in their serum exosomes than those without BM. Clinical investigations have manifested that the exosomal miR‐140‐3p overexpression connects with serum prostate‐specific antigen (PSA) levels and Gleason grade in patients with PCa. Osteoblast‐derived exosomal miR‐140‐3p targeting ACER2 activates the AKT/mTOR pathway in vitro, inhibits autophagy, and promotes PCa cell proliferation, invasion, and migration. miR‐140‐3p significantly increased tumorigenesis and metastasis of LNCaP in vitro. Bone metastatic PCa tissues exhibited elevated levels of miR‐140‐3p, p‐GSK3, p‐mTOR, p62, p‐AKT (S473), and p‐AKT (T308) contrasted with non‐BM tissues. Moreover, their expression was intensified in the metastatic bone tissues. However, ACER2 and LC3 II showed opposite expression patterns. Based on our study outcomes, the evidence suggests that osteoblast‐derived miR‐140‐3p inhibition of autophagy through the AKT/mTOR pathway is involved in PCa progression. Osteoblast‐secreted exosomal miR‐140‐3p activates the AKT/mTOR pathway by targeting ACER2, inhibiting autophagy, and promoting the progression of PCa cells in vitro. Moreover, miR‐140‐3p induces the progression and metastasis of PCa in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsProstatic NeoplasmsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktAutophagyExosomesOsteoblastsMaleHumansAnimalsMiceCell Line, TumorSignal TransductionGene Expression Regulation, NeoplasticCell ProliferationDisease ProgressionMice, NudeBone NeoplasmsCell MovementMice, Inbred BALB C

Stichwörter der Autor:innen

ACER2exosomesmiR‐140‐3pprostate cancer

Substanzen

MicroRNAsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMTOR protein, humanMirn140 microRNA, human

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Huadu Hospital, Southern Medical University (People's Hospital of Huadu District), Guangzhou, Guangdong, China.
  • Department of Urology, Dongguan Tungwah Hospital, Dongguan, Guangdong, China.
  • Department of Urology, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, China.
  • Medical Simulation Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
  • Tianjin Medical University, Tianjin, China.

ORCID-Profile: Ying Liu, Shisheng Chen, Kuo Guo, Siyuan Ma, Xi Wang, Qianping Liu, Rongxin Yan, Yuerong Huang, Tian Li, Shuhua He, Jialiang Hui

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Science and Technology Projects in Guangzhou
  • Science and Technology Planning Project of Huadu District, Guangzhou
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Chen, S., Guo, K., Ma, S., Wang, X., Liu, Q., Yan, R., Huang, Y., Li, T., He, S., & Hui, J. (2024). Osteoblast‐derived exosomal miR ‐140‐3p targets ACER2 and increases the progression of prostate cancer via the AKT/mTOR pathway‐mediated inhibition of autophagy. The FASEB Journal, 38(23). https://doi.org/10.1096/fj.202401480r

Vancouver

Liu Y, Chen S, Guo K, Ma S, Wang X, Liu Q, et al. Osteoblast‐derived exosomal miR ‐140‐3p targets ACER2 and increases the progression of prostate cancer via the AKT/mTOR pathway‐mediated inhibition of autophagy. The FASEB Journal. 2024;38(23). doi:10.1096/fj.202401480r

BibTeX
@article{Liu2024,
  author = {Liu, Ying and Chen, Shisheng and Guo, Kuo and Ma, Siyuan and Wang, Xi and Liu, Qianping and Yan, Rongxin and Huang, Yuerong and Li, Tian and He, Shuhua and Hui, Jialiang},
  title = {Osteoblast‐derived exosomal miR ‐140‐3p targets ACER2 and increases the progression of prostate cancer via the AKT/mTOR pathway‐mediated inhibition of autophagy},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {23},
  doi = {10.1096/fj.202401480r}
}
Kostenlos starten →